"Sorting" SERCA2a: A novel therapeutic strategy in heart failure?
- PMID: 30144996
- PMCID: PMC6478160
- DOI: 10.1016/j.ijcard.2018.08.053
"Sorting" SERCA2a: A novel therapeutic strategy in heart failure?
Conflict of interest statement
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
Comment on
-
SNX17 produces anti-arrhythmic effects by preserving functional SERCA2a protein in myocardial infarction.Int J Cardiol. 2018 Dec 1;272:298-305. doi: 10.1016/j.ijcard.2018.07.025. Epub 2018 Jul 4. Int J Cardiol. 2018. PMID: 30025651
References
-
- Bers DM, Calcium cycling and signaling in cardiac myocytes, Annu Rev Physiol 70 (2008) 23–49. - PubMed
-
- Chelu MG, Wehrens XH, Sarcoplasmic reticulum calcium leak and cardiac arrhythmias, Biochem Soc Trans 35 (2007) 952–956. - PubMed
-
- Baker DL, Hashimoto K, Grupp IL, Ji Y, Reed T, Loukianov E, et al., Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts, Circ Res 83 (1998) 1205–1214. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
